Invesco Ltd. Adma Biologics, Inc. Transaction History
Invesco Ltd.
- $453 Billion
- Q1 2024
A detailed history of Invesco Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 7,804,227 shares of ADMA stock, worth $89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,804,227
Previous 6,111,773
27.69%
Holding current value
$89 Million
Previous $27.6 Million
86.45%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding ADMA
# of Institutions
224Shares Held
174MCall Options Held
85.5KPut Options Held
12.8K-
Black Rock Inc. New York, NY18.2MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$145 Million0.0% of portfolio
-
State Street Corp Boston, MA10.6MShares$120 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL10.5MShares$119 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO7.13MShares$81.3 Million0.03% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.24B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...